Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€20.97

€20.97

2.900%
0.59
2.900%
?
 
18:07 / Tradegate WKN: 940561 / Symbol: GLAXF / Name: GlaxoSmithKline / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

GlaxoSmithKline plc Stock

There is an upward development for GlaxoSmithKline plc compared to yesterday, with an increase of €0.59 (2.900%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the GlaxoSmithKline plc stock is not clear.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for GlaxoSmithKline plc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of GlaxoSmithKline plc in the next few years

Pros
?
B****
?
S********** s********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of GlaxoSmithKline plc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
GlaxoSmithKline plc 2.900% -0.318% -4.140% 25.927% 3.954% 15.178% 4.874%
AstraZeneca plc 2.390% 2.488% -3.762% 31.636% 17.255% 79.362% 101.493%
Merck KGaA 2.620% 4.448% -6.877% 17.290% -26.392% 83.257% 55.808%
Eli Lilly Corp. 3.760% -3.946% -1.853% 67.358% 9.570% 159.808% 289.393%

Comments

Buy GlaxoSmithKline plc
Show more

News

New Large-Scale Observational Study Shows COVID-19 Could Create Vulnerability to Shingles for People Age 50+: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23828/GlaxoSmithKline-Logo.svg.png
New Large-Scale Observational Study Shows COVID-19 Could Create Vulnerability to Shingles for People Age 50+


According to a new study conducted by GSK, people age 50 or older in the US who have had COVID-19 may be at greater risk of developing shingles – a painful rash – compared to those who haven’t been

Alacer Corp. Launches New Eco-Conscious Toothpaste Brand Natean®: https://mms.businesswire.com/media/20220304005602/en/1379399/5/natean_201221_07275_V2.jpg
Alacer Corp. Launches New Eco-Conscious Toothpaste Brand Natean®


Alacer Corp. today announced the launch of Natean®, a new eco-conscious oral healthcare brand providing products to consumers looking for nature-inspired toothpastes that deliver essential oral

Routine Vaccination Rates in Teens and Adults Continue to Lag Behind Pre-Pandemic Levels, Follow-up Analysis Shows: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23828/GlaxoSmithKline-Logo.svg.png
Routine Vaccination Rates in Teens and Adults Continue to Lag Behind Pre-Pandemic Levels, Follow-up Analysis Shows


Centers for Disease Control and Prevention (CDC)-recommended vaccinations for teens and adults continued to lag in 2020 and into the summer of 2021, according to a follow-up claims analysis